|
|
Protegrins
We claim: 1. A purified and isolated or recombinantly produced compound having the formula: ##STR9## or a pharmaceutically acceptable salt or an N-terminal acylated or C-...
|
|
|
Antibiotic cryptdin peptides and methods of their use
The present invention provides a substantially purified cryptdin peptide having a consensus amino acid sequence: X.sub.1 -C-X.sub.2 -C-R-X.sub.3 -C-X.sub.4 -E-X.sub.5 -C-...
|
|
|
Cyclic peptides having broad spectrum antimicrobial activity
OF THE INVENTION 5.1 Definitions "Peptidomimetic Moiety:" As used herein, "peptidomimetic moiety" refers to an organic molecule that mimics the secondary structure of a ...
|
|
|
Vaccine for cytomegalovirus
What is claimed is: 1. A method for vaccinating a susceptible host to confer humoral immunity to human cytomegalovirus (hCMV), said method comprising inoculating the ...
|
|
|
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
Methods and compositions are provided for labeling T cells according to the specificity of their antigen receptor. A stable multimeric complex is prepared with major ...
|
|
|
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
OF THE PREFERRED EMBODIMENTS According to one aspect of the present invention, a nonapeptide (9 amino acid peptide) of the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID ...
|
|
|
CTL epitope analogs
Accordingly, this invention comprises a method of producing a human cytomegalovirus peptide cytotoxic T lymphocyte epitope analog with improved immunogenic potency and ...
|
|
|
HCMV-reactive T cells and uses therefor
OF THE PREFERRED EMBODIMENTS A nonapeptide having the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID NO:1) is an immunogenic epitope of pp65 from CMV laboratory strains A...
|
|
|
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
Accordingly, one aspect of the present invention relates to immunologically active peptides, and functional variants thereof, capable of eliciting a cellular immune ...
|
|
|
Synthetic peptide having an ionophoric and antimicrobial activity
OF THE INVENTION Synthetic peptide P1 of the present invention is comprised by 26 amino acids. The natural existence of this peptide in bacteria and animals has not ...
|